Insider: Hamilton James C Chief Medical Officer - ARROWHEAD PHARMACEUTICALS, INC.
| Company Holdings |
| Direct | Indirect Ownership | Total | |
| Shares | 236,958 | 0 | 236,958 |
| Value | $14,909,397.36 | $0.00 | $14,909,397.36 |
Trans. Date |
Trans. Type |
Shares |
Ownership Type |
Issue Type |
Price |
Trans. Value |
Total Shares Owned |
|---|---|---|---|---|---|---|---|
| 03/05/2026 | DDS | 10,000 | Direct | COM | $64.19 | $641,900.00 | 236,958 |
| 01/05/2026 | DDS | 6,090 | Direct | COM | $62.28 | $379,285.20 | 201,407 |
| 01/05/2026 | DDS | 4,625 | Direct | COM | $61.24 | $283,235.00 | 207,497 |
| 01/05/2026 | DDS | 12,711 | Direct | COM | $63.95 | $812,868.45 | 173,904 |
| 01/05/2026 | DDS | 14,792 | Direct | COM | $63.01 | $932,043.92 | 186,615 |
| 01/05/2026 | DDS | 1,200 | Direct | COM | $64.49 | $77,388.00 | 172,704 |
| 01/05/2026 | DDS | 309 | Direct | COM | $68.00 | $21,012.00 | 171,958 |
| 01/05/2026 | DDS | 437 | Direct | COM | $65.97 | $28,828.89 | 172,267 |
| 10/01/2025 | DDS | 20,000 | Direct | COM | $35.00 | $700,000.00 | 212,122 |
| 09/12/2025 | DDS | 15,000 | Direct | COM | $30.00 | $450,000.00 | 232,122 |
| 09/02/2025 | DDS | 15,000 | Direct | COM | $25.00 | $375,000.00 | 247,122 |
| 08/15/2025 | DDS | 9,389 | Direct | COM | $20.00 | $187,780.00 | 262,122 |
| 08/13/2025 | DDS | 611 | Direct | COM | $20.00 | $12,220.00 | 271,511 |
| 04/01/2024 | DDS | 6,000 | Direct | COM | $28.03 | $168,180.00 | 204,851 |
| 01/12/2024 | DDS | 4,238 | Direct | COM | $36.47 | $154,559.86 | 214,553 |
| 01/12/2024 | DDS | 3,702 | Direct | COM | $37.37 | $138,343.74 | 210,851 |
| 06/30/2023 | DDS | 3,000 | Direct | COM | $35.53 | $106,590.00 | 188,484 |
| 01/05/2023 | DDS | 7,230 | Direct | COM | $37.40 | $270,402.00 | 198,057 |
| 01/05/2023 | DDS | 6,573 | Direct | COM | $37.40 | $245,830.20 | 191,484 |
| 01/03/2023 | DDS | 136 | Direct | COM | $40.54 | $5,513.44 | 151,158 |
| 01/03/2023 | DDS | 300 | Direct | COM | $39.74 | $11,922.00 | 151,294 |
| 01/03/2023 | DDS | 2,837 | Direct | COM | $38.53 | $109,309.61 | 151,594 |
| 01/03/2023 | DDS | 1,194 | Direct | COM | $37.46 | $44,727.24 | 154,431 |
| 01/03/2023 | DDS | 1,642 | Direct | COM | $37.49 | $61,558.58 | 149,516 |
| 01/03/2023 | DDS | 3,682 | Direct | COM | $38.52 | $141,830.64 | 145,834 |
| 1 2 Next Last You are at page 1 of 2 pages |
|
Transaction Type Key First letter: A = Acquired, D = Disposed Second letter: A = Grant, award or other acquisition pursuant to Rule 16b-3(d) C = Conversion of derivative security | D = Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | E = Expiration of short derivative position | F = Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3. | G = Gift | H = Expiration (or cancellation) of long derivative position with value received | I = Discretionary transaction in accordance with Rule 16b-3(f) | J = Other | L = Small acquisition under Rule 16a-6 | M = Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | O = Exercise of out-of-the-money derivative security | P = Open market or private purchase | S = Open market or private sale | U = Disposition pursuant to a tender of shares in a change of control transaction | W = Acquisition or disposition by will or the laws of descent and distribution | X = Exercise of in-the-money or at-the-money derivative security | Z = Deposit into or withdrawal from voting trust |
 |
Send to Excel |
© 2000 - 2026 Zacks Investment Research